Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients

Published:2020-04 Issue: Volume:61 Page:101898
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Benavides-Cordoba Vicente,Aviles Sebastian,Ascuntar Camila,Orozco Lina,Mosquera Ricardo,Rivera Julian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference31 articles.

1. COPD: the patient perspective;Jones;Int. J. Chronic Obstr. Pulm. Dis.,2016

2. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019;Singh;Eur. Respir. J.,2019

3. Perioperative pulmonary medication management;Renew;Curr. Clin. Pharmacol.,2017

4. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis;Rodrigo;Int. J. Chronic Obstr. Pulm. Dis.,2017

5. The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD;Anzueto;Int. J. Chronic Obstr. Pulm. Dis.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2024-10

2. Efectos de la rehabilitación pulmonar en pacientes con EPOC según la clasificación GOLD 2020 en Cali, Colombia;Rehabilitación;2024-01

3. Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator;Evidence-Based Complementary and Alternative Medicine;2022-07-09

4. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial;Therapeutic Advances in Respiratory Disease;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3